Investor Presentation - First Six Months of 2021

101 Investor presentation First six months of 2021 GLP-1 market share and market growth in Region China 100% 80% 60% 40% 20% GLP-1 market growth and Novo Nordisk market share 0% May 2018 NN market share -Market growth (right axis) -NN growth (right axis) Source: IQVIA, May 2021, Value, MAT; Share of growth not depicted due to too high numbers; NN: Novo Nordisk 85% DKK million 545 78% 62% 93% GLP-1 market size and growth -79% 60 316 ~63% China 48 970 85% May May 2021 2020 Novo Nordisk Eli Lilly Novo Nordisk Others Competitors May 2021

View entire presentation